Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Fitch Ratings
Fitch Global Pharmaceutical R&D Quarterly: New Medicines in 2009 On Track to Exceed 2008
June 24th, 2009
Over the next two quarters as many as eight highly-promising new drug candidates may be successfully commercialized despite higher hurdles at government drug regulatory agencies, according to Fitch Ratings. In its quarterly global pharmaceutical report, Fitch says the total amount of marketing clearances this year may exceed the 24 new molecular entities and biologics approved in 2008 helped by the carryover of potential drug candidates with extended review deadlines. Presently, there are almost 90 new molecular entities and vaccines from Fitch-rated drug developers in late-stage clinical testing, of which 17 may be registered with U.S. and European regulators by the end of the...
Source: Vaccine Weekly (2009-06-24)
|
